Previous close | 10,920.00 |
Open | 0.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 288,836 |
Market cap | 696.2B |
Beta (5Y monthly) | 0.68 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 25 July 2024 - 29 July 2024 |
Forward dividend & yield | 100.00 (0.95%) |
Ex-dividend date | 27 Dec 2023 |
1y target est | 13,200.00 |
Boryung, a leading healthcare investment company, announced the launch of the 2024 Humans In Space (HIS) Challenge in collaboration with global partners. The HIS Challenge, now in its third year, is an idea competition Boryung has led since 2022 to build a global space healthcare ecosystem by gathering various space healthcare leaders and ideas.
Boryung, a leading healthcare investment company, has announced that it successfully hosted the Humans In Space (HIS) Symposium co-located with Accelerating Space Commerce, Exploration, and New Discovery (ASCEND). Powered by the American Institute of Aeronautics and Astronautics (AIAA), ASCEND is recognized as the world's premier collaborative, outcomes-driven, interdisciplinary space event. This year's conference, held from October 23 to 25 in Las Vegas, marks the first time that AIAA has enter
Boryung, a leading healthcare investment company, has announced its partnership with the American Institute of Aeronautics and Astronautics (AIAA) to bring the Humans In Space (HIS) Symposium to the upcoming 2023 ASCEND event. Powered by AIAA, ASCEND – which stands for Accelerating Space Commerce, Exploration, and New Discovery – is the world's premier collaborative, outcomes-driven, interdisciplinary event and will be held this year from October 23 to 25 at Caesars Forum in Las Vegas.